Yilmaz, Orhan
Torres, Tiago https://orcid.org/0000-0003-0404-0870
Article History
Received: 15 July 2024
Accepted: 5 August 2024
First Online: 15 August 2024
Declarations
:
: Orhan Yilmaz has nothing to disclose. Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz and UCB. Tiago Torres is an Editorial Board member of<i> Dermatology and Therapy</i>. Tiago Torres was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.